Home LiteratureArticle Details
PMID: 20799954 Published · epublish English Journal Article Research Support, Non-U.S. Gov't

Role of microRNA-199a-5p and discoidin domain receptor 1 in human hepatocellular carcinoma invasion.

Molecular cancer ·Vol. 9 ·2010-08-27 ·Pages 227

Shen Q, Cicinnati VR, Zhang X, Iacob S, Weber F, Sotiropoulos GC, Radtke A, Lu M, Paul A, Gerken G, Beckebaum S

Abstract

Micro-ribonucleic acid (miRNA)-199a-5p has been reported to be decreased in hepatocellular carcinoma (HCC) compared to normal tissue. Discoidin domain receptor-1 (DDR1) tyrosine kinase, involved in cell invasion-related signaling pathway, was predicted to be a potential target of miR-199a-5p by the use of miRNA target prediction algorithms. The aim of this study was to investigate the role of miR-199a-5p and DDR1 in HCC invasion. Mature miR-199a-5p and DDR1 expression were evaluated in tumor and adjacent non-tumor liver tissues from 23 patients with HCC undergoing liver resection and five hepatoma cell lines by the use of real-time quantitative RT-PCR (qRT-PCR) analysis. The effect of aberrant miR-199a-5p expression on cell invasion was assessed in vitro using HepG2 and SNU-182 hepatoma cell lines. Luciferase reporter assay was employed to validate DDR1 as a putative miR-199a-5p target gene. Regulation of DDR1 expression by miR-199a-5p was assessed by the use qRT-PCR and western blotting analysis. A significant down-regulation of miR-199a-5p was observed in 65.2% of HCC tissues and in four of five cell lines. In contrast, DDR1 expression was significantly increased in 52.2% of HCC samples and in two of five cell lines. Increased DDR1 expression in HCC was associated with advanced tumor stage. DDR1 was shown to be a direct target of miR-199a-5p by luciferase reporter assay. Transfection of miR-199a-5p inhibited invasion of HepG2 but not SNU-182 hepatoma cells. Decreased expression of miR-199a-5p contributes to increased cell invasion by functional deregulation of DDR1 activity in HCC. However, the effect of miR-199a-5p on DDR1 varies among individuals and hepatoma cell lines. These findings may have significant translational relevance for development of new targeted therapies as well as prognostic prediction for patients with HCC.

MeSH Terms
Blotting, Western Carcinoma, Hepatocellular/genetics,metabolism,pathology Cell Line, Tumor Discoidin Domain Receptors Hep G2 Cells Humans Liver/metabolism Liver Neoplasms/genetics,metabolism,pathology MicroRNAs/genetics,metabolism Receptor Protein-Tyrosine Kinases/genetics,metabolism Receptors, Mitogen/genetics,metabolism Reverse Transcriptase Polymerase Chain Reaction
Chemicals
MicroRNAs Receptors, Mitogen mirn199 microRNA, human Discoidin Domain Receptors Receptor Protein-Tyrosine Kinases
Authors & Affiliations
11 authors, click to expand affiliations / ORCID
Shen Qingli
Department of Gastroenterology and Hepatology, University Hospital Essen, Essen, Germany.
Cicinnati Vito R
Zhang Xiaoyong
Iacob Speranta
Weber Frank
Sotiropoulos Georgios C
Radtke Arnold
Lu Mengji
Paul Andreas
Gerken Guido
Beckebaum Susanne
References (50)
50 references, click to expand
  1. Sorafenib in advanced hepatocellular carcinoma.
    N Engl J Med. 2008 Jul 24;359(4):378-90 PMID: 18650514
  2. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes.
    Genome Biol. 2002 Jun 18;3(7):RESEARCH0034 PMID: 12184808
  3. microRNAs as oncogenes and tumor suppressors.
    Dev Biol. 2007 Feb 1;302(1):1-12 PMID: 16989803
  4. Control of translation and mRNA degradation by miRNAs and siRNAs.
    Genes Dev. 2006 Mar 1;20(5):515-24 PMID: 16510870
  5. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets.
    Cell. 2005 Jan 14;120(1):15-20 PMID: 15652477
  6. RNA integrity and the effect on the real-time qRT-PCR performance.
    Mol Aspects Med. 2006 Apr-Jun;27(2-3):126-39 PMID: 16469371
  7. RNAi: the nuts and bolts of the RISC machine.
    Cell. 2005 Jul 15;122(1):17-20 PMID: 16009129
  8. MicroRNAs silence gene expression by repressing protein expression and/or by promoting mRNA decay.
    Cold Spring Harb Symp Quant Biol. 2006;71:523-30 PMID: 17381335
  9. Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs.
    Nature. 2005 Feb 17;433(7027):769-73 PMID: 15685193
  10. MicroRNAs--micro in size but macro in function.
    FEBS J. 2008 Oct;275(20):4929-44 PMID: 18754771
  11. Evolution of microRNA expression during human bronchial squamous carcinogenesis.
    Eur Respir J. 2009 Feb;33(2):352-9 PMID: 19010987
  12. Association of MicroRNA expression in hepatocellular carcinomas with hepatitis infection, cirrhosis, and patient survival.
    Clin Cancer Res. 2008 Jan 15;14(2):419-27 PMID: 18223217
  13. Discoidin domain receptors: structural relations and functional implications.
    FASEB J. 1999;13 Suppl:S77-82 PMID: 10352148
  14. MicroRNA expression profiling of single whole embryonic stem cells.
    Nucleic Acids Res. 2006 Jan 24;34(2):e9 PMID: 16434699
  15. Cancer genomics: small RNAs with big impacts.
    Nature. 2005 Jun 9;435(7043):745-6 PMID: 15944682
  16. p53 induction and activation of DDR1 kinase counteract p53-mediated apoptosis and influence p53 regulation through a positive feedback loop.
    EMBO J. 2003 Mar 17;22(6):1289-301 PMID: 12628922
  17. miRGen: a database for the study of animal microRNA genomic organization and function.
    Nucleic Acids Res. 2007 Jan;35(Database issue):D149-55 PMID: 17108354
  18. A receptor tyrosine kinase found in breast carcinoma cells has an extracellular discoidin I-like domain.
    Proc Natl Acad Sci U S A. 1993 Jun 15;90(12):5677-81 PMID: 8390675
  19. MicroRNA-directed cleavage of HOXB8 mRNA.
    Science. 2004 Apr 23;304(5670):594-6 PMID: 15105502
  20. MicroRNA signatures in human ovarian cancer.
    Cancer Res. 2007 Sep 15;67(18):8699-707 PMID: 17875710
  21. Modulation of hepatitis C virus RNA abundance by a liver-specific MicroRNA.
    Science. 2005 Sep 2;309(5740):1577-81 PMID: 16141076
  22. A microRNA expression signature of human solid tumors defines cancer gene targets.
    Proc Natl Acad Sci U S A. 2006 Feb 14;103(7):2257-61 PMID: 16461460
  23. qBase relative quantification framework and software for management and automated analysis of real-time quantitative PCR data.
    Genome Biol. 2007;8(2):R19 PMID: 17291332
  24. Micro RNAs are complementary to 3' UTR sequence motifs that mediate negative post-transcriptional regulation.
    Nat Genet. 2002 Apr;30(4):363-4 PMID: 11896390
  25. Expression and mutation analysis of the discoidin domain receptors 1 and 2 in non-small cell lung carcinoma.
    Br J Cancer. 2007 Mar 12;96(5):808-14 PMID: 17299390
  26. Identification of metastasis-related microRNAs in hepatocellular carcinoma.
    Hepatology. 2008 Mar;47(3):897-907 PMID: 18176954
  27. Small dsRNAs induce transcriptional activation in human cells.
    Proc Natl Acad Sci U S A. 2006 Nov 14;103(46):17337-42 PMID: 17085592
  28. Principles of cancer therapy: oncogene and non-oncogene addiction.
    Cell. 2009 Mar 6;136(5):823-37 PMID: 19269363
  29. Posttranscriptional regulation of the heterochronic gene lin-14 by lin-4 mediates temporal pattern formation in C. elegans.
    Cell. 1993 Dec 3;75(5):855-62 PMID: 8252622
  30. Future of molecular profiling of human hepatocellular carcinoma.
    Future Oncol. 2007 Aug;3(4):429-39 PMID: 17661718
  31. The expression profile of microRNAs in a model of 7,12-dimethyl-benz[a]anthrance-induced oral carcinogenesis in Syrian hamster.
    J Exp Clin Cancer Res. 2009 May 13;28:64 PMID: 19435529
  32. Diagnosis and treatment of hepatocellular carcinoma.
    Gastroenterology. 2008 May;134(6):1752-63 PMID: 18471552
  33. MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer.
    Gastroenterology. 2007 Aug;133(2):647-58 PMID: 17681183
  34. Real-time quantification of microRNAs by stem-loop RT-PCR.
    Nucleic Acids Res. 2005 Nov 27;33(20):e179 PMID: 16314309
  35. Molecular pathogenesis of human hepatocellular carcinoma.
    Nat Genet. 2002 Aug;31(4):339-46 PMID: 12149612
  36. Profiling microRNA expression in hepatocellular carcinoma reveals microRNA-224 up-regulation and apoptosis inhibitor-5 as a microRNA-224-specific target.
    J Biol Chem. 2008 May 9;283(19):13205-15 PMID: 18319255
  37. Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissues.
    Oncogene. 2006 Apr 20;25(17):2537-45 PMID: 16331254
  38. MicroRNA gene expression profile of hepatitis C virus-associated hepatocellular carcinoma.
    Hepatology. 2008 Apr;47(4):1223-32 PMID: 18307259
  39. Global cancer statistics, 2002.
    CA Cancer J Clin. 2005 Mar-Apr;55(2):74-108 PMID: 15761078
  40. Discoidin domain receptor 1 tyrosine kinase has an essential role in mammary gland development.
    Mol Cell Biol. 2001 Apr;21(8):2906-17 PMID: 11283268
  41. Vertebrate microRNA genes.
    Science. 2003 Mar 7;299(5612):1540 PMID: 12624257
  42. Switching from repression to activation: microRNAs can up-regulate translation.
    Science. 2007 Dec 21;318(5858):1931-4 PMID: 18048652
  43. Distinct structural characteristics of discoidin I subfamily receptor tyrosine kinases and complementary expression in human cancer.
    Oncogene. 1995 Feb 2;10(3):609-18 PMID: 7845687
  44. Validation of putative reference genes for gene expression studies in human hepatocellular carcinoma using real-time quantitative RT-PCR.
    BMC Cancer. 2008 Nov 27;8:350 PMID: 19036168
  45. Micro-RNAs associated with metastasis in uveal melanoma identified by multiplexed microarray profiling.
    Melanoma Res. 2008 Jun;18(3):184-90 PMID: 18477892
  46. Altered MicroRNA expression in cervical carcinomas.
    Clin Cancer Res. 2008 May 1;14(9):2535-42 PMID: 18451214
  47. MicroRNAs: genomics, biogenesis, mechanism, and function.
    Cell. 2004 Jan 23;116(2):281-97 PMID: 14744438
  48. Regulation by let-7 and lin-4 miRNAs results in target mRNA degradation.
    Cell. 2005 Aug 26;122(4):553-63 PMID: 16122423
  49. Isolation and characterization of an epithelial-specific receptor tyrosine kinase from an ovarian cancer cell line.
    Cell Growth Differ. 1994 Nov;5(11):1173-83 PMID: 7848919
  50. Overexpression of discoidin domain receptor 1 increases the migration and invasion of hepatocellular carcinoma cells in association with matrix metalloproteinase.
    Oncol Rep. 2007 Dec;18(6):1435-41 PMID: 17982627
Article Info
Journal
Molecular cancer
Abbr.
Mol Cancer
ISSN
1476-4598
Published
2010-08-27
Epub
2010-00-27
Pages
227
Language
English
Region
England
NLM ID
101147698
PMCID
PMC2939569
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com